Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Bulletin of Experimental Biology and Medicine
Metadata
Title
Modeling of Lymphogenous and Hematogenous Metastasizing from Murine В16 Melanoma in Rats
Publication date
01-10-2017
Published in
Bulletin of Experimental Biology and Medicine / Issue 6/2017
Print ISSN: 0007-4888
Electronic ISSN: 1573-8221
DOI
https://doi.org/10.1007/s10517-017-3905-9

Other articles of this Issue 6/2017

Bulletin of Experimental Biology and Medicine 6/2017 Go to the issue

OriginalPaper

Selectivity in Physiological Action of Nitric Oxide: A Hypothetical Mechanism

GENERAL PATHOLOGY AND PATHOPHYSIOLOGY

Role of β2-Adrenoreceptors in Adrenergic Anti-Inflammatory Mechanism in Sepsis

MORPHOLOGY AND PATHOMORPHOLOGY

Mast Cells in Renal Cancer: Clinical Morphological Correlations and Prognosis

OriginalPaper

Comparative Study of Sutureless Fixation of Lightweight Surgical Meshes for Hernia Repair in a Rat Model

PHARMACOLOGY AND TOXICOLOGY

Studying the Toxic Effects of Some Biologically Active Peptides on the Model of Mouse Embryonic Stem Cells

OriginalPaper

Elimination of a Viscumin-Ferromagnetic Nanoparticles Conjugate from the Tumor Nodule in Mice

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits